Snapchat SNAP Stock Analysis and why you should avoid Snapchat SNAP stock

FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb) – Biotech Investments

Formycon AG / Key word(s): Regulatory Approval FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb) 28-Jun-2024 / 23:50 CET/CEST Disclosure of an inside information acc.

June 30, 2024

Blood Test for Colon Cancer Screening Secures FDA Panel’s Blessing

An FDA panel on Thursday endorsed a blood-based test for colorectal cancer (CRC) screening in adults 45 years and older at average risk for the

May 25, 2024

Atrial fibrillation diagnosis associated with 45% increased risk of mild cognitive impairment

Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive impairment (MCI) among a cohort of 4.3 million individuals in the

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.